Target ALS, a consortium of at least 18 laboratories, including ones at CUMC and at Johns Hopkins, will work to find biological “targets,” that could be used to test potential drug therapies for ALS. CUMC's Christopher E. Henderson is Target ALS's scientific director.
A study that casts doubt on whether being overweight is associated with a shorter life span has sparked 2013’s first public health controversy—and a fiery one at that.
Awardees are Robert J. Winchester at Columbia University Medical Center; Peter K. Gregersen at the Feinstein Institute for Medical Research in Manhasset, New York; and Lars Klareskog of Stockholm’s Karolinska Institute.
“In the past, you had to set up incredibly expensive and time-consuming clinical trials to test a hypothesis,” said CUMC's Dr. Nicholas Tatonetti. “Now we can look at data already collected in electronic medical records and begin to tease out information.”
Where does the Affordable Care Act go from here? Joshua Brooks of The 2X2 Project interviews Columbia University Mailman School of Public Health’s Dr. Michael Sparer.
They may have wings, but fruit flies spend plenty of time on their feet. A Columbia University Medical Center team has developed a more accurate and sophisticated way to quantify such movement.
